These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22503475)

  • 1. Treatment response of cutaneous leishmaniasis due to Leishmania aethiopica to cryotherapy and generic sodium stibogluconate from patients in Silti, Ethiopia.
    Negera E; Gadisa E; Hussein J; Engers H; Kuru T; Gedamu L; Aseffa A
    Trans R Soc Trop Med Hyg; 2012 Aug; 106(8):496-503. PubMed ID: 22503475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study.
    El-Sayed M; Anwar AE
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):335-40. PubMed ID: 19744259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of cryotherapy and intralesional pentostam in treatment of cutaneous leishmaniasis.
    Gurei MS; Tatli N; Ozbilge H; Erel O; Seyrek A; Kocyigit A; Ulukanligil M
    J Egypt Soc Parasitol; 2000 Apr; 30(1):169-76. PubMed ID: 10786028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate.
    Solomon M; Baum S; Barzilai A; Pavlotsky F; Trau H; Schwartz E
    J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1189-92. PubMed ID: 19298486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis.
    Soto J; Valda-Rodriquez L; Toledo J; Vera-Navarro L; Luz M; Monasterios-Torrico H; Vega J; Berman J
    Am J Trop Med Hyg; 2004 Nov; 71(5):577-81. PubMed ID: 15569787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya.
    Moore E; O'Flaherty D; Heuvelmans H; Seaman J; Veeken H; de Wit S; Davidson RN
    Bull World Health Organ; 2001; 79(5):388-93. PubMed ID: 11417033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and treatment response of cutaneous leishmaniasis in North-West Ethiopia.
    Fikre H; Mohammed R; Atinafu S; van Griensven J; Diro E
    Trop Med Int Health; 2017 Oct; 22(10):1293-1301. PubMed ID: 28712122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and pharmacokinetics of antimony in cutaneous leishmaniasis patients treated with sodium stibogluconate.
    Zaghloul IY; Radwan MA; Al Jaser MH; Al Issa R
    J Clin Pharmacol; 2010 Nov; 50(11):1230-7. PubMed ID: 20663995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers.
    Solomon M; Pavlotzky F; Barzilai A; Schwartz E
    J Am Acad Dermatol; 2013 Feb; 68(2):284-9. PubMed ID: 22858005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis.
    Solomon M; Baum S; Barzilai A; Scope A; Trau H; Schwartz E
    J Am Acad Dermatol; 2007 Apr; 56(4):612-6. PubMed ID: 17276541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging cutaneous leishmaniasis in Sirte-Libya: epidemiology, recognition and management.
    Fathy FM; El-Kasah F; El-Ahwal AM
    J Egypt Soc Parasitol; 2009 Dec; 39(3):881-905. PubMed ID: 20120753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of short-duration (twice weekly) intralesional sodium stibogluconate in treatment of cutaneous Leishmaniasis in India.
    Bumb RA; Mehta RD; Ghiya BC; Jakhar R; Prasad N; Soni P; Lezama-Davila C; Satoskar AR
    Br J Dermatol; 2010 Oct; 163(4):854-8. PubMed ID: 20500797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy of single-dose radiofrequency-induced heat therapy vs. intralesional antimonials for cutaneous leishmaniasis in India.
    Bumb RA; Prasad N; Khandelwal K; Aara N; Mehta RD; Ghiya BC; Salotra P; Wei L; Peters S; Satoskar AR
    Br J Dermatol; 2013 May; 168(5):1114-9. PubMed ID: 23298394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel.
    Wortmann G; Miller RS; Oster C; Jackson J; Aronson N
    Clin Infect Dis; 2002 Aug; 35(3):261-7. PubMed ID: 12115091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Cutaneous Leishmaniasis Caused by Leishmania aethiopica: A Systematic Review.
    van Griensven J; Gadisa E; Aseffa A; Hailu A; Beshah AM; Diro E
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004495. PubMed ID: 26938448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case 4-2005: sodium stibogluconate for cutaneous leishmaniasis.
    Hartzell JD; Aronson N
    N Engl J Med; 2005 May; 352(18):1929. PubMed ID: 15872214
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness of intralesional sodium stibogluconate for the treatment of localized cutaneous leishmaniasis at Boru Meda general hospital, Amhara, Ethiopia: Pragmatic trial.
    Tilahun Zewdu F; Tessema AM; Zerga AA; van Henten S; Lambert SM
    PLoS Negl Trop Dis; 2022 Sep; 16(9):e0010578. PubMed ID: 36084153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of clinical isolates of Leishmania aethiopica to miltefosine, paromomycin, amphotericin B and sodium stibogluconate using amastigote-macrophage in vitro model.
    Utaile M; Kassahun A; Abebe T; Hailu A
    Exp Parasitol; 2013 May; 134(1):68-75. PubMed ID: 23434530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis.
    Asilian A; Sadeghinia A; Faghihi G; Momeni A; Amini Harandi A
    Ann Trop Med Parasitol; 2003 Jul; 97(5):493-8. PubMed ID: 12930612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New world cutaneous leishmaniasis: obstacles in initiating treatment with sodium stibogluconate in 2 travelers from Texas.
    Darling MD; Reichenberg JS; Gavino AC
    J Drugs Dermatol; 2013 Apr; 12(4):476-8. PubMed ID: 23652898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.